Literature DB >> 29024167

Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).

Shila Azodi1, Govind Nair2, Yoshimi Enose-Akahata1, Emily Charlip1, Ashley Vellucci1, Irene Cortese3, Jenifer Dwyer3, B Jeanne Billioux1, Chevaz Thomas3, Joan Ohayon3, Daniel S Reich2, Steven Jacobson1.   

Abstract

OBJECTIVE: Previous work measures spinal cord thinning in chronic progressive myelopathies, including human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS). Quantitative measurements of spinal cord atrophy are important in fully characterizing these and other spinal cord diseases. We aimed to investigate patterns of spinal cord atrophy and correlations with clinical markers.
METHODS: Spinal cord cross-sectional area was measured in individuals (24 healthy controls [HCs], 17 asymptomatic carriers of HTLV-1 (AC), 47 HAM/TSP, 74 relapsing-remitting MS [RRMS], 17 secondary progressive MS [SPMS], and 40 primary progressive MS [PPMS]) from C1 to T10. Clinical disability scores, viral markers, and immunological parameters were obtained for patients and correlated with representative spinal cord cross-sectional area regions at the C2 to C3, C4 to C5, and T4 to T9 levels. In 2 HAM/TSP patients, spinal cord cross-sectional area was measured over 3 years.
RESULTS: All spinal cord regions are thinner in HAM/TSP (56 mm2 [standard deviation, 10], 59 [10], 23 [5]) than in HC (76 [7], 83 [8], 38 [4]) and AC (71 [7], 78 [9], 36 [7]). SPMS (62 [9], 66 [9], 32 [6]) and PPMS (65 [11], 68 [10], 35 [7]) have thinner cervical cords than HC and RRMS (73 [9], 77 [10], 37 [6]). Clinical disability scores (Expanded Disability Status Scale [p = 0.009] and Instituto de Pesquisas de Cananeia [p = 0.03]) and CD8+ T-cell frequency (p = 0.04) correlate with T4 to T9 spinal cord cross-sectional area in HAM/TSP. Higher cerebrospinal fluid HTLV-1 proviral load (p = 0.01) was associated with thinner spinal cord cross-sectional area. Both HAM/TSP patients followed longitudinally showed thoracic thinning followed by cervical thinning.
INTERPRETATION: Group average spinal cord cross-sectional area in HAM/TSP and progressive MS show spinal cord atrophy. We further hypothesize in HAM/TSP that is possible that neuroglial loss from a thoracic inflammatory process results in anterograde and retrograde degeneration of axons, leading to the temporal progression of thoracic to cervical atrophy described here. Ann Neurol 2017;82:719-728.
© 2017 American Neurological Association.

Entities:  

Mesh:

Year:  2017        PMID: 29024167     DOI: 10.1002/ana.25072

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination.

Authors:  Andrea Pennati; Emily A Nylen; Ian D Duncan; Jacques Galipeau
Journal:  J Neurosci       Date:  2020-05-19       Impact factor: 6.167

Review 2.  Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.

Authors:  Yoshimi Enose-Akahata; Ashley Vellucci; Steven Jacobson
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

Review 3.  Antiviral Effects of Oleandrin.

Authors:  Robert A Newman; K Jagannadha Sastry; Ravit Arav-Boger; Hongyi Cai; Rick Matos; Robert Harrod
Journal:  J Exp Pharmacol       Date:  2020-11-16

Review 4.  Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Sepehr Aghajanian; Majid Teymoori-Rad; Ghazale Molaverdi; Sayed-Hamidreza Mozhgani
Journal:  Front Microbiol       Date:  2020-12-22       Impact factor: 5.640

5.  NMOSD-like and longitudinal extensive HTLV1-associated myelitis are extremes that flank an overlooked continuum.

Authors:  Mickael Bonnan; Stéphane Olindo; Aissatou Signate; Quentin Lobjois; Maeva Stephant; Dalia Dimitri Boulos; Philippe Cabre
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-07-31

6.  Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.

Authors:  Yair Mina; Shila Azodi; Tsemacha Dubuche; Frances Andrada; Ikesinachi Osuorah; Joan Ohayon; Irene Cortese; Tianxia Wu; Kory R Johnson; Daniel S Reich; Govind Nair; Steven Jacobson
Journal:  Neuroimage Clin       Date:  2021-04-28       Impact factor: 4.881

7.  Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1).

Authors:  Luiz C F Romanelli; Débora M Miranda; Anna B F Carneiro-Proietti; Marcelo Mamede; Herika M M Vasconcelos; Marina L Martins; Anísia S D Ferreira; Daniela V F Rosa; Jonas J Paula; Marco A Romano-Silva; Rodrigo Nicolato
Journal:  PLoS Negl Trop Dis       Date:  2018-08-27

Review 8.  Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Yoshimi Enose-Akahata; Steven Jacobson
Journal:  Retrovirology       Date:  2019-11-29       Impact factor: 4.602

9.  Heritability of cervical spinal cord structure.

Authors:  Linda Solstrand Dahlberg; Olivia Viessmann; Clas Linnman
Journal:  Neurol Genet       Date:  2020-02-26

10.  Unsuspected Involvement of Spinal Cord in Alzheimer Disease.

Authors:  Roberta Maria Lorenzi; Fulvia Palesi; Gloria Castellazzi; Paolo Vitali; Nicoletta Anzalone; Sara Bernini; Matteo Cotta Ramusino; Elena Sinforiani; Giuseppe Micieli; Alfredo Costa; Egidio D'Angelo; Claudia A M Gandini Wheeler-Kingshott
Journal:  Front Cell Neurosci       Date:  2020-01-30       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.